Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06946576 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of Fetoscopic Endoluminal Tracheal Occlusion in Congenital Diaphragmatic Hernia
A Phase 3 study, sponsored by Oregon Health and Science University.
- Not yet
- Registry status
- Phase 3
- Development phase
- 80
- Enrollment target
NCT06946576: Clinical Trial Phase 3 study, sponsored by Oregon Health and Science University.
NCT06946576 is a Phase 3 study that has not yet begun recruiting, run by Oregon Health and Science University. The registered enrollment target is 80 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06946576, a Phase 3 study, has not yet begun recruiting, sponsored by Oregon Health and Science University.
- NOT YET RECRUITING
- Registry status
- Phase 3
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in cases of severe Congenital Diaphragmatic Hernia (CDH).
Primary Outcome
Whether placement and removal of the FETO device was successful or not
Interventions
- DEVICE Fetoscopic Endoluminal Tracheal Occlusion (FETO) Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2025-09 |
| Est. Completion | 2030-04 |
| Phase | Phase 3 |
What is known before NCT06946576 opens enrollment
NCT06946576 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Fetoscopic Endoluminal Tracheal Occlusion (FETO) Procedure is the first listed.
NCT06946576 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06946576 about?
NCT06946576 is a clinical study titled "Safety and Efficacy of Fetoscopic Endoluminal Tracheal Occlusion in Congenital Diaphragmatic Hernia". The purpose of this study is to evaluate the safety and efficacy of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in cases of severe Congenital Diaphragmatic Hernia (CDH).
What is the current status of trial NCT06946576?
This trial is currently not yet recruiting. It is a Phase 3 study. The enrollment target is 80 participants. The study started on 2025-09. Estimated completion is 2030-04.
What interventions are being tested in trial NCT06946576?
The interventions under investigation include: Fetoscopic Endoluminal Tracheal Occlusion (FETO) Procedure (DEVICE).
Who is sponsoring clinical trial NCT06946576?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06946576's enrollment target sits among peer trials
80 1755th of 2000 higher than 233 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia